Human ES cells had just been isolated for the first time, and researchers were excited about
their potential use in regenerative medicine.
Not exact matches
Through CBR ®, we also help families to preserve newborn stem cells, which are
used today
in transplant
medicine for certain cancers and blood, immune and metabolic disorders, and have the
potential to play a valuable role
in the ongoing development of
regenerative medicine.
The production of virus - free iPS cells, albeit from embryonic fibroblasts, addresses a critical safety concern for
potential use of iPS cells
in regenerative medicine.
«This shows iPS cells have a lot of problems, but that doesn't mean they don't have
potential — just not with the established methodologies
used to create them,» says tissue engineer Anthony Atala, director of Wake Forest University Baptist Medical Center's Institute for
Regenerative Medicine in Winston — Salem, N.C. «It's a solvable problem, but it looks as if one should look away from methods that don't genetically modify the cell.»
As part of a «Body on a Chip» project funded by the Defense Threat Reduction Agency, scientists at Wake Forest Institute for
Regenerative Medicine,
in collaboration with partners from around the country, are developing miniature hearts, livers, blood vessels and lungs that will be
used to predict the effects of chemical and biologic agents and
used to test the effectiveness of
potential treatments.
Today, however, drug - based
medicine invariably
uses chemicals that have not one iota of
regenerative potential; to the contrary, they almost always interfere with bodily self - renewal
in order to suppress the symptoms against which they are applied.